0001400482-17-000035.txt : 20170404 0001400482-17-000035.hdr.sgml : 20170404 20170404203217 ACCESSION NUMBER: 0001400482-17-000035 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170404 FILED AS OF DATE: 20170404 DATE AS OF CHANGE: 20170404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KUBOTA PHARMACEUTICAL HOLDINGS CO LTD CENTRAL INDEX KEY: 0001400482 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981295657 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4-20-3 EBISU STREET 2: SHIBUYA-KU CITY: TOKYO STATE: M0 ZIP: 150-0013 BUSINESS PHONE: 81 3 5789-5872 MAIL ADDRESS: STREET 1: 4-20-3 EBISU STREET 2: SHIBUYA-KU CITY: TOKYO STATE: M0 ZIP: 150-0013 FORMER COMPANY: FORMER CONFORMED NAME: ACUCELA INC. DATE OF NAME CHANGE: 20131217 FORMER COMPANY: FORMER CONFORMED NAME: Acucela Inc DATE OF NAME CHANGE: 20070523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DANSE EDWARD H CENTRAL INDEX KEY: 0001016353 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55133 FILM NUMBER: 17740795 MAIL ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92715 4 1 wf-form4_149135232340376.xml FORM 4 X0306 4 2017-04-04 0 0001400482 KUBOTA PHARMACEUTICAL HOLDINGS CO LTD M?????? 0001016353 DANSE EDWARD H C/O ACUCELA INC. 1301 2ND AVE., SUITE 4200 SEATTLE WA 98101 0 1 0 0 Chief Business Officer Common Stock 2017-04-04 4 S 0 1100 6.75 D 72314 D On November 30, 2016, the issuer completed its change in place of incorporation, pursuant to which Kubota Pharmaceutical Holdings Co., Ltd., a Japanese corporation ("Kubota Holdings"), became the publicly traded parent company of the Kubota group of companies. Each issued and outstanding share of common stock of Acucela Inc., a Washington corporation ("Acucela US"), was cancelled and converted into one share of common stock of Kubota Holdings. Pursuant to Rule 12g-3(a) under the Securities Exchange Act of 1934, as amended, Kubota Holdings is the successor issuer to Acucela US. The issuer's common stock trades on the Tokyo Stock Exchange under the code 4596. The sale on this Form 4 was effected pursuant to a non-discretionary, Issuer-mandated sell-to-cover arrangement, in order to cover tax withholding incident to the vesting of shares under the reporting person's restricted stock grant. /s/ John Gebhart as attorney-in-fact for Edward Danse 2017-04-04